Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05873699
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Pancreatic Cyst
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hyperpolarized 13-C-pyruvate — DRUGGiven by Injection
Study Details
To learn if Hyperpolarized C-Pyruvate Magnetic Resonance (HP-MR) Spectroscopic Imaging can help doctors detect low-risk (benign) and high-risk (malignant) cysts.
Key Dates
- Start date
- Aug 18, 2023
- Status verified
- Feb 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic ImagingParticipants will have the HP-MR scan within the 4 weeks before your scheduled surgery. Hyperpolarized C-Pyruvate will be injected by vein during the scan. Your vital signs (temperature, blood pressure, heart rate and respiration \[breathing\]) will be monitored during the scan. The estimated time of the scan is a couple of minutes, but you may be in the room of the MRI for up to 30 minutes for preparation. The entire process of obtaining the MRI (and possible blood draw) may be up to half of a work day (not including your personal travel time).
Primary Outcome Measure
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Florencia McAllister, MD(713) 745-0914
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Florencia McAllister, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic LesionsRecruiting · Ohio State University Comprehensive Cancer Center · Scottsdale, Arizona
- Pancreas Registry and High Risk RegistryRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas CancerRecruiting · Stanford University · Stanford, California
- A Study of Blood Based Biomarkers for Pancreas AdenocarcinomaRecruiting · Memorial Sloan Kettering Cancer Center · Middletown, New Jersey